<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Anthera Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $65,500,000
    • PRE-MONEY EVAULATION
      $8,811,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Paul F. Truex
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    InnaMed, Inc.

    InnaMed, Inc.

    InnaMed is developing a comprehensive care management platform. Our team is develo...

    InnaMed is developing a comprehensive care mana...

    Amount Raised:    $1,070,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    ImmuCell Corporation

    ImmuCell Corporation

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose is to create scientifically-proven...

    ImmuCell Corporation’s (Nasdaq: ICCC) purpose...

    Filing Type:    PU
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    VIVUS, Inc.

    VIVUS, Inc.

    With demonstrated clinical development and commercialization expertise, VIVUS is d...

    With demonstrated clinical development and comm...

    Filing Type:    PU
    Amgen Inc.

    Amgen Inc.

    Amgen is committed to unlocking the potential of biology for patients suffering fr...

    Amgen is committed to unlocking the potential o...

    Filing Type:    PU
    Avalon GloboCare Corp.

    Avalon GloboCare Corp.

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a global intelligent biotech developer an...

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a glob...

    Filing Type:    PU
    WAVE Life Sciences Ltd.

    WAVE Life Sciences Ltd.

    We are a biotechnology company focused on delivering transformational therapies fo...

    We are a biotechnology company focused on deliv...

    Filing Type:    PU
    Esperion Therapeutics, Inc.

    Esperion Therapeutics, Inc.

    Esperion is a pharmaceutical company passionately committed to developing and comm...

    Esperion is a pharmaceutical company passionate...

    Filing Type:    PU
    OptiNose, Inc.

    OptiNose, Inc.

    Optinose is a specialty pharmaceutical company focused on creating and bringing to...

    Optinose is a specialty pharmaceutical company ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.